News

Global X Investments Launches New 3X & -3X ETFs for Investors

Global X Investments Launches New 3X & -3X ETFs for Investors

Expanding Investment Opportunities

Global X Investments Canada Inc. has recently enhanced its investment offerings by launching six new Exchange-Traded Funds (ETFs). These new products are part of the BetaPro suite designed for innovative trading strategies, providing 3X and -3X exposure to crucial sectors including U.S. Treasuries, Semiconductors, and the S&P/TSX 60 Index. This move makes Global X a frontrunner in offering leveraged trading options for savvy investors.

Overview of the New ETFs

The latest additions to the BetaPro suite enable traders to capitalize on daily market movements with high leverage. The ETFs aim to offer gains that correspond to 300% of the daily performance of their underlying indices. Importantly, the management fees for all these ETFs have been set at a competitive rate of 0.65%. This special tiered fee structure will be effective until the end of the current financial year.

Why Choose BetaPro ETFs?

BetaPro is known for being the largest and longest-running family of leveraged and inverse ETFs in Canada. With a history of over 17 years in the market, they have successfully launched a total of 38 ETFs so far. With these new releases, traders are given more choices to manage risk and leverage the fluctuations of the financial markets effectively.

Insight from Leadership

Erik Sloane, Executive Vice President of Global X, emphasized the significance of these new products. He noted that the recent trends in the semiconductor industry and the dynamic nature of U.S. Treasuries make these ETFs particularly relevant. Sloane stated, "Our mission is to empower traders by providing tools to navigate market volatility effectively. These new ETFs are a testament to that goal." This perspective reflects the firm’s commitment to meet the evolving needs of Canadian traders.

About the New ETFs

Each new ETF in the BetaPro lineup is structured to deliver daily investment results that mirror their respective indices. It’s important to note that these funds are designed for short-term trading and can lead to significant fluctuations in returns due to the nature of compounding daily returns. Investors interested in these ETFs should be prepared for active monitoring.

List of New ETFs

Here are some of the specific ETFs introduced:

  • BetaPro 3x S&P/TSX 60 Daily Leveraged Bull Alternative ETF (TCND): 3X leverage on the S&P/TSX 60 Index.
  • BetaPro -3x S&P/TSX 60 Daily Leveraged Bear Alternative ETF (SCND): -3X leverage on the S&P/TSX 60 Index.
  • BetaPro 3x US Treasury 20+ Year Daily Leveraged Bull Alternative ETF (TTLT): 3X leverage targeting U.S. Treasury bonds.
  • BetaPro -3x US Treasury 20+ Year Daily Leveraged Bear Alternative ETF (STLT): -3X leverage on U.S. Treasury bonds.
  • BetaPro 3x Semiconductor Daily Leveraged Bull Alternative ETF (SOXL): 3X exposure to the semiconductor sector.
  • BetaPro -3x Semiconductor Daily Leveraged Bear Alternative ETF (SOXS): -3X exposure to the semiconductor sector.

Investor Considerations

Investing in leveraged and inverse ETFs can be beneficial but carries significant risk. These funds require not just capital, but also a thorough understanding of the market movements. The New ETFs from Global X are tailored for active traders looking to exploit intraday price movements, making them ideal for those with a high risk tolerance.

Incorporating Currency Hedging

The structure of these ETFs includes built-in currency hedging aimed at mitigating the risks associated with currency fluctuations, especially relevant for Canadian investors dealing with U.S. dollar investments. The goal is to provide a trading experience that maintains fidelity to the underlying assets' performance without interference from currency value shifts.

Conclusion

As the marketplace evolves, so do the tools available to investors. Global X Investments through its BetaPro brand continues to innovate in the ETF space, providing opportunities for traders to leverage movements in sought-after financial instruments. These new offerings reflect a commitment to not just growth in product range but also enhanced trading experiences for Canadian investors.

Frequently Asked Questions

1. What types of exposure do the new BetaPro ETFs provide?

The new ETFs offer 3X and -3X exposure to sectors such as U.S. Treasuries and Semiconductors, as well as the S&P/TSX 60 Index.

2. What is the management fee for these ETFs?

The management fee for all BetaPro ETFs has been set at 0.65%, which is quite competitive in the market.

3. Are these ETFs suitable for long-term investors?

These ETFs are designed for daily trading and may not be suitable for long-term investment strategies due to the nature of leveraged ETFs and their compounding effects.

4. How does currency hedging work with these ETFs?

The ETFs employ currency hedging to neutralize U.S. dollar exposure, which helps maintain performance that accurately reflects the underlying indices without excessive currency fluctuations.

5. Where can I find more information about the ETFs?

Further details can be found on the official Global X website, which provides comprehensive insights into each ETF's structure and objectives.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles